X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5004) 5004
animals (3739) 3739
proto-oncogene proteins c-kit - metabolism (3479) 3479
mice (2629) 2629
female (2406) 2406
male (2382) 2382
proto-oncogene proteins c-kit - genetics (1922) 1922
c-kit (1775) 1775
oncology (1557) 1557
expression (1405) 1405
immunohistochemistry (1395) 1395
cell biology (1363) 1363
middle aged (1241) 1241
adult (1197) 1197
mutation (1152) 1152
signal transduction (1036) 1036
aged (1016) 1016
hematology (967) 967
cancer (911) 911
cells, cultured (887) 887
stem cells (881) 881
imatinib mesylate (816) 816
pathology (794) 794
phosphorylation (766) 766
apoptosis (764) 764
mice, inbred c57bl (763) 763
biochemistry & molecular biology (761) 761
cell line, tumor (759) 759
gene expression (759) 759
tumors (657) 657
research (656) 656
activation (654) 654
cell proliferation (653) 653
differentiation (625) 625
proto-oncogene proteins - metabolism (595) 595
cell differentiation (588) 588
analysis (576) 576
flow cytometry (535) 535
proteins (530) 530
cell line (503) 503
immunology (492) 492
benzamides (488) 488
mutations (486) 486
medicine, research & experimental (483) 483
proto-oncogene proteins - genetics (483) 483
kinases (479) 479
tyrosine kinase (476) 476
prognosis (472) 472
receptor (469) 469
proto-oncogene proteins c-kit - biosynthesis (467) 467
proto-oncogene proteins c-akt - metabolism (461) 461
aged, 80 and over (460) 460
rats (456) 456
antineoplastic agents - pharmacology (454) 454
hematopoietic stem cells - metabolism (445) 445
stem cell factor (441) 441
stem cell factor - metabolism (441) 441
cell proliferation - drug effects (440) 440
gastrointestinal stromal tumors (435) 435
proliferation (433) 433
growth-factor (431) 431
progenitor cells (430) 430
genetic aspects (427) 427
signal transduction - drug effects (421) 421
research article (418) 418
cells (414) 414
multidisciplinary sciences (405) 405
growth (402) 402
imatinib (401) 401
biomarkers, tumor - metabolism (397) 397
pyrimidines - pharmacology (397) 397
apoptosis - drug effects (396) 396
leukemia (394) 394
antineoplastic agents - therapeutic use (392) 392
in-vitro (391) 391
hematopoietic stem cells - cytology (388) 388
protein kinase inhibitors - pharmacology (384) 384
mast cells - metabolism (383) 383
proto-oncogene proteins c-kit (379) 379
mice, knockout (377) 377
gene (376) 376
reverse transcriptase polymerase chain reaction (372) 372
mice, transgenic (370) 370
molecular sequence data (363) 363
stem-cells (363) 363
gastrointestinal stromal tumors - pathology (362) 362
blotting, western (356) 356
gastrointestinal stromal tumors - metabolism (349) 349
adolescent (346) 346
tyrosine (343) 343
gene expression regulation, neoplastic (342) 342
medicine (342) 342
mouse (339) 339
time factors (338) 338
receptor tyrosine kinase (337) 337
base sequence (333) 333
identification (332) 332
stem cells - metabolism (331) 331
phenotype (330) 330
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7167) 7167
Chinese (152) 152
Japanese (39) 39
Russian (15) 15
French (11) 11
Polish (6) 6
German (4) 4
Spanish (4) 4
Ukrainian (3) 3
Korean (2) 2
Portuguese (2) 2
Romanian (2) 2
Bulgarian (1) 1
Hungarian (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 1476-5594, 2012, Volume 32, Issue 22, pp. 2767 - 2781
.... Here, we show that c-Kit is not just a marker of OTICs, but also a critical mediator of the phenotype that can be a viable target for the treatment of ovarian cancer... 
b-catenin | chemoresistance | c-Kit | ovarian cancer | ABCG2 | beta-catenin | SURFACE EPITHELIUM | ONCOLOGY-GROUP | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLATINUM-RESISTANT | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | PHASE-II TRIAL | ONCOLOGY | SEROUS CARCINOMA | GENETICS & HEREDITY | IMATINIB MESYLATE | EPITHELIAL OVARIAN | CLINICOPATHOLOGICAL FEATURES | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Paclitaxel - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Tumor Microenvironment | Neoplasm Proteins - metabolism | Proto-Oncogene Proteins c-kit - metabolism | Wnt Proteins - metabolism | Cell Hypoxia | Neoplastic Stem Cells - metabolism | RNA Interference | Cell Transformation, Neoplastic - genetics | ATP-Binding Cassette Transporters - metabolism | Female | Proto-Oncogene Proteins c-kit - genetics | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Cell Survival - drug effects | Cisplatin - pharmacology | Pyrimidines - pharmacology | Cell Transformation, Neoplastic - metabolism | Imatinib Mesylate | Piperazines - pharmacology | beta Catenin - metabolism | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Wnt Signaling Pathway - drug effects | Mice, Nude | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2008, Volume 112, Issue 12, pp. 4646 - 4654
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2011, Volume 184, Issue 1, pp. 116 - 123
Journal Article
PloS one, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173913
Journal Article
Circulation research, ISSN 0009-7330, 03/2012, Volume 110, Issue 5, pp. 701 - 715
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2011, Volume 108, Issue 6, pp. 2450 - 2455
.... We and others have identified activating mutations of C-KIT in nearly half of patients with t (8;21) AML. To test the hypothesis that activating C-KIT mutations cooperate... 
Cell growth | Receptors | 3T3 cells | NIH 3T3 cells | Myeloid leukemia | Leukemia | Mice | Transplantation | Genetic mutation | Blood | Interleukin-3 | Mouse model | Combinatorial therapy | Targeted therapy | Stem cell factor | TRANSCRIPTION FACTORS | GENE-MUTATIONS | targeted therapy | interleukin-3 | PROGNOSTIC IMPACT | stem cell factor | mouse model | MULTIDISCIPLINARY SCIENCES | FUSION GENE | MURINE MODEL | combinatorial therapy | MYELOPROLIFERATIVE DISEASE | EMBRYONIC LETHALITY | STI-571 INHIBITION | GASTROINTESTINAL STROMAL TUMORS | RECEPTOR TYROSINE KINASE | Chromosomes, Human, Pair 8 - genetics | NIH 3T3 Cells | Chromosomes, Human, Pair 21 - metabolism | Oncogene Proteins, Fusion - metabolism | Cytarabine - pharmacology | Humans | Leukemia, Myeloid, Acute - metabolism | Proto-Oncogene Proteins c-kit - metabolism | Cell Transformation, Neoplastic - genetics | Leukemia, Lymphoid - metabolism | Antimetabolites, Antineoplastic - pharmacology | Proto-Oncogene Proteins c-kit - genetics | Leukemia, Lymphoid - genetics | Protein Structure, Tertiary | Core Binding Factor Alpha 2 Subunit - metabolism | Leukemia, Myeloid, Acute - pathology | Mice, Transgenic | Leukemia, Lymphoid - pathology | Chromosomes, Human, Pair 21 - genetics | Cell Transformation, Neoplastic - metabolism | RUNX1 Translocation Partner 1 Protein | Chromosomes, Human, Pair 8 - metabolism | Animals | Oncogene Proteins, Fusion - genetics | Mutation | Cell Transformation, Neoplastic - pathology | Core Binding Factor Alpha 2 Subunit - genetics | Leukemia, Myeloid, Acute - genetics | Translocation, Genetic - genetics | Gene mutations | Health aspects | Biological Sciences
Journal Article
Oncogene, ISSN 0950-9232, 02/2012, Volume 31, Issue 7, pp. 869 - 883
.... However, the functional significance of c-Kit expression in the mammary gland is unknown... 
progenitor | Brca1 | c-Kit | mammary | LINEAGE-COMMITMENT | STEM-CELLS | ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | PROTEIN-TYROSINE KINASE | CELL BIOLOGY | SIGNAL-TRANSDUCTION | FUNCTIONAL MAMMARY-GLAND | 2 SPLICE FORMS | ONCOLOGY | ESTROGEN-RECEPTOR-ALPHA | GENETICS & HEREDITY | NIH 3T3 Cells | Cell Proliferation | Epithelial Cells - metabolism | Humans | Gene Expression Regulation, Neoplastic | Cell Survival - genetics | Apoptosis - genetics | Gene Expression Profiling | Mammary Neoplasms, Experimental - metabolism | Proto-Oncogene Proteins c-kit - metabolism | Stem Cells - metabolism | Mammary Neoplasms, Experimental - genetics | Breast Neoplasms - metabolism | Cell Differentiation - genetics | RNA Interference | BRCA1 Protein - metabolism | Mammary Neoplasms, Experimental - pathology | Estrogen Receptor alpha - metabolism | Female | Proto-Oncogene Proteins c-kit - genetics | Cells, Cultured | Signal Transduction - genetics | Reverse Transcriptase Polymerase Chain Reaction | Mammary Glands, Animal - cytology | BRCA1 Protein - genetics | Animals | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Mammary Glands, Animal - metabolism | Breast Neoplasms - pathology | Mice | Mutation | Signal transduction | Cell growth | Breast cancer | Gene expression | Flow cytometry | Cell survival | BRCA1 protein | Colonies | Estrogens | Epithelium | c-Kit protein | Overexpression | Stem cells | KIT protein | Lyn protein | Mammary gland | Differentiation | Apoptosis | Tumors
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue 9, pp. 2409 - 2414
...), focusing on the expression and mutations of c-KIT. Immunohistochemical expression of c-KIT/CD117, p63, CD5 and neuroendocrine markers, as well as mutational analysis of c-KIT exons 9, 11, 13, 14, 17 by direct sequencing of 48 cases of TCs... 
mutation | CD117 | thymus | immunohistochemistry | c-KIT | carcinoma | Immunohistochemistry | C-KIT | Carcinoma | Mutation | Thymus | ONCOLOGY | THYMOMA | SORAFENIB | EXPRESSION | IMATINIB MESYLATE | Humans | Middle Aged | Thymus Neoplasms - genetics | Male | Antineoplastic Agents - therapeutic use | Thymoma - genetics | Mutation, Missense | Benzenesulfonates - pharmacology | Sunitinib